TCL Archive NCI Told It Needs Overview Of Basic Research For Visibility And To Pursue Breakthroughs July 14, 1978
TCL Archive Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial November 10, 1989
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
